prison courtyard

New study highlights opioid overdose risk following release from Oregon prisons

By Sheraz Sadiq (OPB)

In Oregon, people released from prison were 10 times more likely to overdose on opioids compared to the general population, according to a new study that tracked prison release and overdose data from 2014 to 2018. The risk of overdose doubled during the first two weeks of release, and formerly incarcerated women were almost twice as likely as men to experience an opioid overdose. A team of scientists from Oregon State University, Oregon Health & Science University and the Oregon Department of Corrections shared these findings which were published in the Journal of Substance Use and Addiction Treatment. The study looked at both fatal and non-fatal opioid overdoses using data collected from the Department of Corrections, state Medicaid insurance claims for emergency room and hospital admissions, as well as death certificates. Joining us are Dan Hartung, a professor in the College of Pharmacy at Oregon State University and Elizabeth Waddell, an associate professor at the OHSU-PSU School of Public Health, to talk about the research and new efforts in Oregon to expand access to substance use treatment both during and after incarceration.

Similar Posts

  • Narcan at music festivals? The life-saving drug naloxone is coming to a concert near you

    David Oliver | USA Today It’s festival season, meaning fabulous flower crowns, loud live music and Narcan. Yes, the overdose-reversing drug Narcan (naloxone) will be available at music festivals near you this year – and with good reason, experts say. Drugs and alcohol are staple at music festivals and many often overdo it. Combine that with the overwhelming presence of fentanyl in the drug…

  • Biden-⁠Harris Administration Designates Fentanyl Combined with Xylazine as an Emerging Threat to the United States

    ATLANTA, GA – Today, Dr. Rahul Gupta, Director of the White House Office of National Drug Control Policy (ONDCP), has officially designated fentanyl adulterated or associated with xylazine as an emerging threat to the United States. Xylazine is a non-opioid tranquilizer approved by the Food and Drug Administration (FDA) for veterinary use but not human use….

  • Texas scientists create fentanyl vaccine to combat opioid epidemic

    By Adithi Ramakrishnan | The Dallas Morning News To combat the fentanyl epidemic in the United States, researchers at the University of Houston have created a fentanyl vaccine that could help prevent overdoses. They aim to test the vaccine in a human trial within the next year. Fentanyl is a synthetic opioid drug that kills…

  • SAMHSA Applauds Expansion of Access to Medication for Opioid Use Disorder (MOUD)

    The Substance Abuse and Mental Health Services Administration (SAMHSA) applauds provisions included in the 2023 Consolidated Appropriations Act (P.L. 117-328) that will significantly expand access to medication for opioid use disorder (MOUD). The act, signed into law by President Biden on Dec. 29, 2022, amended the Controlled Substances Act to eliminate the requirement for qualified…

  • Fentanyl Vaccine Potential ‘Game Changer’ for Opioid Epidemic 

    Study Suggests New Vaccine Could Prevent Deadly Opioid from Entering the Brain By Laurie Fickman 713-743-8454 November 14, 2022 A research team led by the University of Houston has developed a vaccine targeting the dangerous synthetic opioid fentanyl that could block its ability to enter the brain, thus eliminating the drug’s “high.” The breakthrough discovery could have…

Leave a Reply

Your email address will not be published. Required fields are marked *